AXON TERMINAL HYPEREXCITABILITY ASSOCIATED WITH EPILEPTOGENESIS IN-VITRO .2. PHARMACOLOGICAL REGULATION BY NMDA AND GABA(A) RECEPTORS

Citation
Sf. Stasheff et al., AXON TERMINAL HYPEREXCITABILITY ASSOCIATED WITH EPILEPTOGENESIS IN-VITRO .2. PHARMACOLOGICAL REGULATION BY NMDA AND GABA(A) RECEPTORS, Journal of neurophysiology, 70(3), 1993, pp. 976-984
Citations number
49
Categorie Soggetti
Neurosciences,Physiology
Journal title
ISSN journal
00223077
Volume
70
Issue
3
Year of publication
1993
Pages
976 - 984
Database
ISI
SICI code
0022-3077(1993)70:3<976:ATHAWE>2.0.ZU;2-T
Abstract
1. The preceding report presented evidence that the kindling-like indu ction of electrographic seizures (EGSs) in the hippocampal slice is ac companied by a lasting increase in the excitability of CA3 axon termin als, which is manifested by an increase in action-potential initiation at this site. In this report we explore the role of the N-methyl-D-as partate (NMDA) receptor in the induction and maintenance of this antid romic firing, as well as the role of the gamma-aminobutyric acid type A (GABA(A)) receptor in regulating this activity once it has been indu ced. 2. Kindling-like stimulus trains (60 Hz, 2s) were delivered to s. radiatum of CA3 at 10-min intervals. As EGSs developed in control art ificial cerebrospinal fluid (ACSF), the frequency of axon terminal fir ing increased markedly (by 10.33 +/- 3.29 spikes/min, mean +/- SE P mu ch less than 0.01). The prior application of the competitive NMDA anta gonist D-2-amino-5-phosphonovaleric acid (D-APV, 50 or 100 muM) preven ted the induction of EGSs and suppressed the increase in terminal firi ng seen in control ACSF (mean increase 1.06 +/- 1.11 spikes/min, P < 0 .02). However, when D-APV was applied only after EGSs and antidromic s pikes were induced in control ACSF, it failed to alter the frequency o f terminal firing (mean 6.44 +/- 2.03 in control ACSF, 8.89 +/- 2.31 i n APV; P much greater than 0.1). Thus the NMDA receptor is required fo r the induction but not maintenance of increased axon terminal firing, as we previously have shown to be the case for EGSs. 3. Measurements of antidromic stimulus threshold at several points along the course of the Schaffer collateral axons of CA3 cells showed that EGS induction is accompanied by a significant decrease in threshold at synaptic term inal regions but not at nonterminal regions. This decrease in threshol d in the terminal region did not occur in separate experiments during which D-APV (50 mum) was preapplied to block the induction of EGSs. Co nsidering the similar effects of D-APV on the induction and maintenanc e of antidromic firing, we conclude that during EGS induction the NMDA receptor mediates a selective increase in the excitability of CA3 axo n terminals, leading to antidromic firing. Once induced, this axon ter minal hyperexcitability is maintained by mechanisms independent of the NMDA receptor. These results also further strengthen the link between axon terminal hyperexcitability and EGS expression. 4. Spontaneous an tidromic action potentials were frequently observed in association wit h spontaneous or evoked GABA(A) receptor-mediated inhibitory postsynap tic potentials (IPSPs). Therefore, in our search for an NMDA receptor- independent mechanism that maintains axon terminal backfiring, we appl ied the GABA(A) antagonists bicuculline methochloride (BIC, 1 or 10 mu M) and picrotoxin (PTX, 1 muM). These agents completely suppressed ant idromic firing in all of seven cells tested. (+/-)-Baclofen (0.5-1 muM ), which suppresses the release of GABA via activation of presynaptic GABA(B) receptors on interneurons, also suppressed antidromic firing, although less dramatically (mean frequency in ACSF: 16.9 +/- 8.81; in baclofen: 5.16 +/- 4.81; P = 0.1). These results demonstrate that the axon terminal backfiring induced by EGS induction is subsequently regu lated by GABA(A) receptors, raising the possibility that GABAergic pre synaptic inhibition is present in the hippocampus and may be upregulat ed in some forms of neural plasticity. 5. We discuss the pharmacologic al regulation of the processes leading to axon terminal backfiring as well as those maintaining this activity once induced. We give special attention to the location of the NMDA receptors responsible for this c hange, to the possible role of presynaptic inhibition in these process es, and to the relationship of terminal backfiring to epileptogenesis and other forms of neural plasticity.